Good Marijuana Dispensary Qualities – Find Your Happy Place
Dispensaries are popping up blocks like coffee shops and the competition is bound to benefit consumers. But what qualities should a good marijuana dispensary have?
Read More
Looking for a marijuana industry career? Here is how to get ready.
Is your next job going to lead to a marijuana industry career? Allow us to be blunt…
Read More
Stages of the Cannabis Plant Growth Cycle
Considering a career as a cannabis Master Grower? Or maybe just looking into growing some good old-fashioned self-supply? We get down to the ground and look at the stages of the cannabis plant growth cycle.
Read More
FEATURED NEWS
The published article features commentary from Hemp, Inc. CEO, Bruce Perlowin, regarding the uncertainty of the cannabis industry with a federal ban on the product and massive costs that many investors did not anticipate. WeedMD Inc. reports net revenues of $6.7 million with a gross margin of 29%. Greenhouse cultivation cost improves to $0.72/gram in Q3. KALY’s current revenues come primarily from the sale of CBD infused products that have utilized KALY’s U.S. Patented Cannabis Extraction Process.Hemp, Inc. CEO Bruce Perlowin Featured in Sinclair Broadcast Coverage About Hemp Stocks Amidst a Congressional Push for Legalization
WeedMD Reports Third Quarter 2019 Financial Results and Announces Strategic Combination with Starseed
KALY – Kali-Extracts Could Reach $1 Million In Total 2019 Revenue
LATEST STOCK NEWS
STAMFORD, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting… Las Vegas, NV, Feb. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, announces launch… DEVON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced the acceptance…Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020
Hemp, Inc. Announces Launch of High-Quality King of Hemp™ Pre-Rolls
Zynerba Pharmaceuticals Announces Presentations at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Annual Meeting
GET LISTED
